Nicoletta Brunelli

Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)

Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli et al. · The Journal of Headache and Pain · 2021 · 150 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Val66Met BDNF Gene Polymorphism Influences Human Motor Cortex Plasticity in Acute Stroke

Vincenzo Di Lazzaro, Giovanni Pellegrino, Giovanni Di Pino et al. · Brain stimulation · 2014 · 77 citations · Full text

Life Sciences, Genetics, Neuroscience +12

Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3‐month observational, longitudinal, cohort, multicenter, Italian real‐life study

Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli et al. · European Journal of Neurology · 2021 · 76 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +17

Maintenance of response and predictive factors of 1‐year <scp>GalcanezumAb</scp> treatment in real‐life migraine patients in <scp>Italy</scp>: The multicenter prospective cohort <scp>GARLIT</scp> study

Fabrizio Vernieri, Nicoletta Brunelli, Marilena Marcosano et al. · European Journal of Neurology · 2022 · 71 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +17

Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study

Fabrizio Vernieri, Nicoletta Brunelli, Roberta Messina et al. · The Journal of Headache and Pain · 2021 · 70 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17